JESSICA LONG: Open Payments
NPI 1679245914 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 28 payments from 11 companies in 2025. Trend: 2023 $1,459 · 2024 $753 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 13 | $265 |
| Paratek Pharmaceuticals, Inc. | 3 | $67 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| ViiV Healthcare Company | 2 | $43 |
| Gilead Sciences, Inc. | 2 | $41 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $33 |
| Melinta Therapeutics, LLC | 1 | $30 |
| Theratechnologies Inc. | 1 | $26 |
| Shionogi Inc | 1 | $21 |
| CorMedix Inc. | 1 | $21 |
Products named: Arikayce, NUZYRA, DOVATO, XERAVA, Rezzayo, ZERBAXA, EGRIFTA, Fetroja.
Industry payments across FL — which companies pay providers there.
